RALEIGH, N.C., Dec. 01, 2016 -- MaxPoint (NASDAQ:MXPT) today announced that Joe Epperson, Co-Founder and Chief Executive Officer of MaxPoint, and Brad Schomber, Chief Financial Officer of MaxPoint, will participate at the following upcoming conferences:
- KeyBanc Capital Markets Consumer Conference, to be held at the InterContinental New York Barclay Hotel in New York, New York, on Tuesday, December 6, 2016;
- Needham & Company’s 19th Annual Growth Conference, to be held at the Lotte New York Palace Hotel in New York, New York, from January 10 to 12, 2017; and
- Noble Financial’s NobleCon13 Investor Conference, to be held at the Boca Raton Resort & Club in Boca Raton, Florida, from January 30 to 31, 2017.
About MaxPoint
MaxPoint is a marketing technology company that generates hyperlocal intelligence to optimize brand and retail performance. We provide a platform for brands to connect the digital world with the physical world through hyperlocal execution, measurement, and consumer insights.
The company’s proprietary Digital Zip® technology and the MaxPoint Intelligence Platform™ predict the most likely buyers of a specific product at a particular retail location and then execute cross-channel digital marketing programs to reach these buyers. For more information, visit maxpoint.com.
Media Contact: Patrick Foarde Ketchum for MaxPoint [email protected] 404.879.9254 or Investor Relations Contact: Denise Garcia [email protected] 800.916.9960


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 



